As a category, target maturity bond ETFs have been well received by investors. However, one knock is the reinvestment risk ...

BMO Capital’s analyst Rufus Hone reiterated a Buy rating on Corpay Inc. (NYSE:CPAY), with an unchanged price target of $410.

BMO Capital Markets analyst Kostas Biliouris reiterated a Hold rating on BridgeBio Pharma Inc. (NASDAQ:BBIO) with an ...